Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany-Reference-Cited by-同舟云学术

Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany

Published:2017-05-08 Issue:7 Volume:58 Page:1208-1216
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Steinig Isabel¹,von Podewils Felix²,Möddel Gabriel³,Bauer Sebastian¹⁴,Klein Karl Martin¹⁴,Paule Esther¹,Reif Philipp S.¹,Willems Laurent M.¹,Zöllner Johann Philipp¹,Kunz Rhina²,Runge Uwe²,Kurlemann Gerhard⁵,Schubert-Bast Susanne¹⁶,Rosenow Felix¹⁴,Strzelczyk Adam¹⁴^ORCID

Affiliation:

1. Epilepsy Center Frankfurt Rhine-Main and Department of Neurology; Goethe-University; Frankfurt am Main Germany

2. Epilepsy Center Greifswald and Department of Neurology; Ernst-Moritz-Arndt-University; Greifswald Germany

3. Department of Sleep Medicine and Neuromuscular Disorders; Epilepsy Center Münster-Osnabrück; Westfälische Wilhelms-University; Münster Germany

4. Epilepsy Center Hessen and Department of Neurology; Philipps-University; Marburg Germany

5. Department of Neuropediatrics; Westfälische Wilhelms-University; Münster Germany

6. Department of Neuropediatrics; Goethe-University; Frankfurt am Main Germany

Funder

Desitin Arzneimittel

Eisai Pharma

UCB Pharma

Deutsche Forschungsgemeinschaft